422RO A phase II study of patritumab deruxtecan (HER3-DXd) in patients (pts) with metastatic breast cancer (MBC)

ESMO Open 2026 Open access

Read full text
Authors: E.P. Hamilton, S. Premji, L. Finney, O. Dosunmu, M. Shastry, R. Meibalane, J. Mortimer, N. A. Bagegni, W.R. Gwin, B. Jacob, T. Beck, D. Toppmeyer
+7 more A.L. Heeke, K. Khoury, A. Sporchia, S. Raja, L. Li, A. Saci, K Landry Truchon
DOI: 10.1016/j.esmoop.2026.107445
Cited by: 1

Fields of Study & Subjects

HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies

Publication details

Journal / source
ESMO Open
Publisher
Elsevier BV
Volume
11
Pages
107445–107445
Publication date
1 May 2026
Language
EN